Browse By Person: Adams, Mark
|Up a level|
Group by: Item Type | Date
Number of items: 17.
Ramsay, Andrew J., Reid, Janet C., Adams, Mark N., Samaratunga, Hemamali, Dong, Ying, Clements, Judith A., et al. (2008) Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). Biological Chemistry, 389(6), pp. 653-668.
He, Yaowu, Wortmann, Andreas, Burke, Leslie, Reid, Janet, Adams, Mark, Abdul-Jabbar, Ibtissam, et al. (2010) Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKC? Journal of Biological Chemistry, 285(34), pp. 26162-26173.
Adams, Mark, Ramachandran, Rithwik, Yau, Mei-Kwan, Suen, Jacky, Fairlie, David, Hollenberg, Morley, et al. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacology and Therapeutics, 130(3), pp. 248-282.
Adams, Mark, Christensen, Melinda, He, Yaowu, Waterhouse, Nigel, & Hooper, John (2011) The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2. PLoS ONE, 6(11), pp. 1-14.
Adams, Mark N. (2012) In vitro and in vivo studies on protease-activated receptor-2. PhD thesis, Queensland University of Technology.
Adams, Mark N., Leong, Vincent, Paquet, Nicolas, Bolderson, Emma, Fennell, Dean A., O'Byrne, Kenneth, et al. (2013) HSSB1: An essential regulator of genomic integrity in lung cancer. In 15th World Conference on Lung Cancer, 27-30 October 2013, Sydney, NSW.
Jekimovs, Christian, Bolderson, Emma, Suraweera, Amila, Adams, Mark, O'Byrne, Kenneth J., & Richard, Derek J. (2014) Chemotherapeutic compounds targeting the DNA double-strand break repair pathways : the good, the bad, and the promising. Frontiers in Oncology, 4(86).
Dong, Ying, Harrington, Brittney S., Adams, Mark N., Wortmann, Andreas, Stephenson, Sally-Anne, Lisle, Jessica E., et al. (2014) Activation of membrane-bound proteins and receptor systems: A link between tissue kallikrein and the KLK-related peptidases. Biological Chemistry, 395(9), pp. 977-990.
Burgess, Joshua T., Croft, Laura V., Wallace, Nathan C., Stephenson, Sally-Anne, Adams, Mark N., Ashton, Nicholas W., et al. (2014) DNA repair pathways and their therapeutic potential in lung cancer. Lung Cancer Management, 3(2), pp. 159-173.
Adams, Mark N., Ashton, Nicholas W., Paquet, Nicolas, O'Byrne, Kenneth J., & Richard, Derek J. (2014) Mechanisms of cisplatin resistance: DNA repair and cellular implications. In Morais, Christudas (Ed.) Advances in Drug Resistance Research. Nova Science Publishers, New York, pp. 1-37.
Paquet, Nicolas, Adams, Mark N., Leong, Vincent, Ashton, Nicholas W., Touma, Christine, Gamsjaeger, Roland, et al. (2015) hSSB1 (NABP2/ OBFC2B) is required for the repair of 8-oxo-guanine by the hOGG1-mediated base excision repair pathway. Nucleic Acids Research, 43(18), pp. 8817-8829.
Box, Joseph K., Paquet, Nicolas, Adams, Mark N., Boucher, Didier, Bolderson, Emma, O’Byrne, Kenneth J., et al. (2016) Nucleophosmin: From structure and function to disease development. BMC Molecular Biology, 17, Article no. 19.
Touma, Christine, Kariawasam, Ruvini, Gimenez, Adrian X., Bernardo, Ray E., Ashton, Nicholas W., Adams, Mark N., et al. (2016) A structural analysis of DNA binding by hSSB1 (NABP2/OBFC2B) in solution. Nucleic Acids Research. (In Press)
Paquet, Nicolas, Adams, Mark N., Ashton, Nicholas W., Touma, Christine, Gamsjaeger, Roland, Cubeddu, Liza, et al. (2016) hSSB1 (NABP2/OBFC2B) is regulated by oxidative stress. Scientific Reports, 6, Article number: 27446.
O'Byrne, K., Adams, M., Burgess, J., & Richard, D. (2016) CDCA3 regulates the cell cycle and modulates cisplatin sensitivity in non-small cell lung cancer. In European Lung Cancer Conference (ELCC 2016), 13 - 16 April 2016, Geneva, Switzerland.
O'Byrne, K., Paquet, N., Box, J.K., Adams, M., & Richard, D. (2016) Examination of EXOSC4 as a new prognostic marker and a novel therapeutic avenue in lung adenocarcinoma. In European Lung Cancer Conference (ELCC 2016), 13 - 16 April 2016, Geneva, Switzerland.
O'Byrne, K.J., Burgess, J., Bolderson, E., Adams, M., Zhang, S-D, & Richard, D. (2016) The overexpression of SASH1 stimulates cell death in lung cancer cells. In European Lung Cancer Conference (ELCC 2016), 13 - 16 April 2016, Geneva, Switzerland.